Data & Analytics

High five: How these companies are leveraging data to engage A-list HCPs

High five: How these companies are leveraging data to engage A-list HCPs

By

In the past, pharma hasn't used data effectively to engage its A-list HCPs. Five companies hope to change that.

Get to know your data scientist: Four data aces share their knowledge

Get to know your data scientist: Four data aces share their knowledge

By

Four data aces share their backgrounds, inspirations, and guiding philosophies

Machine Learning Can Decipher Data

Machine Learning Can Decipher Data

As researchers and analysts, we interact with a wide array of market research pros in the health and wellness space.

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

By

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Bank brand creates own algorithm to avoid YouTube ad pitfalls

Bank brand creates own algorithm to avoid YouTube ad pitfalls

By

US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.

Study says drug development costs much less than previously estimated

Study says drug development costs much less than previously estimated

By

New research suggests that the oft-cited $2.6 billion estimate for bringing a drug to market is significantly overstated.

Roundtable: Market access takes center stage

Roundtable: Market access takes center stage

By

Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.

Five things for pharma marketers to know: Friday, July 28, 2017

Five things for pharma marketers to know: Friday, July 28, 2017

By

Drugmakers inconsistently share clinical trial data; AstraZeneca's share price falls after Mystic results; some pregnancy apps share info with marketers

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

By

The FDA-approved app will allow MS patients to share their medication injection history with HCPs.

4 Ways to Help Pharma Understand and Better Use Big Data

4 Ways to Help Pharma Understand and Better Use Big Data

As drugmakers hire economists and pharmacologists to better grapple with big data, how can ad agencies ensure they're not left behind?

Five things for pharma marketers to know: Thursday, May 25, 2017

Five things for pharma marketers to know: Thursday, May 25, 2017

By

Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug

Nearly every $100,000 drug approved in the last three years was for a rare disease

Nearly every $100,000 drug approved in the last three years was for a rare disease

By

This includes Sarepta Therapeutics' Exondys 5 and Vertex Pharmaceuticals' Orkambi.

Study: One-third of new drugs report safety issues

Study: One-third of new drugs report safety issues

By

Drugs approved through the accelerated approval pathway, as well as psychiatric drugs, were more likely to have a safety issue following FDA approval.

Day 2 at Health Datapalooza

Day 2 at Health Datapalooza

By

The market for health data and technology is growing, but the industry must also address concerns about privacy, standards, and diversity.

Day 1 at Health Datapalooza

Day 1 at Health Datapalooza

By

HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.

Five things for pharma marketers to know: Monday, April 24, 2017

Five things for pharma marketers to know: Monday, April 24, 2017

By

QuintilesIMS partners with Salesforce; the E.U. to decide on new EMA location by June; drugmakers boost lobbying dollars in Q1

Pharma R&D partnerships are on the rise: report

Pharma R&D partnerships are on the rise: report

By

This is likely due, in part, to the increasingly complex nature of new specialty drugs.

Off-label legal settlements do little to change prescribing patterns

Off-label legal settlements do little to change prescribing patterns

By

An analysis of claims data found that an off-label settlement for one Eli Lilly drug did not significantly change how often it was prescribed off-label after the settlements.

Large teaching hospitals more prone to breaches

Large teaching hospitals more prone to breaches

By

These facilities may be more prone to attack because there are more people at them with access to private patient data, whether to conduct medical research or educate new healthcare professionals.

Is a Crisis Brewing for Watson Health?

Is a Crisis Brewing for Watson Health?

By

In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.

Amy Molyneux, Meta

Amy Molyneux, Meta

Amy Molyneux is co-founder and EVP of Meta.

Libbe Englander, Pharm3r

Libbe Englander, Pharm3r

Libbe Englander is founder and CEO of Pharm3r.

Jeff Ceitlin, HVH Patient Precision Analytics

Jeff Ceitlin, HVH Patient Precision Analytics

Jeff Ceitlin is CCO of HVH Patient Precision Analytics.

Digital IDs become focus as drugmakers seek to track doctors' behavior online

Digital IDs become focus as drugmakers seek to track doctors' behavior online

By

Organizations are focusing on better ways to verify HCPs' digital identities.

Drugmakers again boost DTC spending, to $5.6 billion in 2016

Drugmakers again boost DTC spending, to $5.6 billion in 2016

By

Pfizer and Bristol-Myers Squibb were the top spenders last year.

Five things for pharma marketers to know: Friday, February 17, 2017

Five things for pharma marketers to know: Friday, February 17, 2017

By

Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March

MM&M's top 5 stories in January 2017

MM&M's top 5 stories in January 2017

By

Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation

Patients are increasingly asking docs about drugs in DTC ads: poll

Patients are increasingly asking docs about drugs in DTC ads: poll

By

Docs said patients asked about drugs from DTC ads six times in a typical week, compared to just twice a week five years ago.

6 personalization practices from Walgreens' Balance Rewards program

6 personalization practices from Walgreens' Balance Rewards program

By

How the retail pharmacy chain uses customer data to make its marketing messages relevant.

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

By

Deborah Furey will lead the agency's pilot of a new personalized marketing offering.